| |
|
|
|
|
|
SEPS Pharma provides access to its novel prodrug approaches resulting in significant collaborations with pharmaceutical partners. In addition, SEPS Pharma offers a full suite drug delivery and product development services, encompassing preclinical development, preformulation development, formulation development, dosage form development, analytical development and scaling-up.
Currently, SEPS Pharma is performing drug delivery services related to pharmaceutical partner compounds: SMC0101, SMC0102, SMC0103, SMC0104, SMC0105, SMC0201, SMC0301, SMC0302, SMC0303 and SMC0401.
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
